[
    [
        {
            "time": "2019-07-20",
            "original_text": "格隆汇A股公告精选(7.20) | 长城汽车上半年归母净利润预降近六成 多家公司股东抛出大额减持计划",
            "features": {
                "keywords": [
                    "长城汽车",
                    "归母净利润",
                    "预降",
                    "减持计划"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "汽车"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "格隆汇A股公告精选(7.20) | 长城汽车上半年归母净利润预降近六成 多家公司股东抛出大额减持计划",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-01-01",
            "original_text": "药明康德(02359.HK)2018年股权激励计划预留权益数量下调至247.996万份",
            "features": {
                "keywords": [
                    "药明康德",
                    "股权激励",
                    "预留权益",
                    "下调"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "药明康德(02359.HK)2018年股权激励计划预留权益数量下调至247.996万份",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2019-01-01",
            "original_text": "药明康德(603259.SH)披露2019年限制性股票与股票期权激励计划 拟授出权益总计2105.553万份",
            "features": {
                "keywords": [
                    "药明康德",
                    "限制性股票",
                    "股票期权",
                    "激励计划"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "药明康德(603259.SH)披露2019年限制性股票与股票期权激励计划 拟授出权益总计2105.553万份",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-01-01",
            "original_text": "药明康德：推2105万股限制性股票与股票期权激励计划",
            "features": {
                "keywords": [
                    "药明康德",
                    "限制性股票",
                    "股票期权",
                    "激励计划"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "药明康德：推2105万股限制性股票与股票期权激励计划",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-01-01",
            "original_text": "药明康德(603259.SH)披露2019年股票增值权激励计划(草案) 拟授出290.1172万份H股股票增值权",
            "features": {
                "keywords": [
                    "药明康德",
                    "股票增值权",
                    "激励计划",
                    "H股"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "药明康德(603259.SH)披露2019年股票增值权激励计划(草案) 拟授出290.1172万份H股股票增值权",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]